Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

57%

4 of 7 completed trials have results

Key Signals

4 with results

Enrollment Performance

Analytics

N/A

6(85.7%)

Phase 1

1(14.3%)

7Total

N/A(6)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT03267134Not ApplicableCompleted

Hydrus Microstent for Refractory Open-Angle Glaucoma

Role: lead

NCT02024464Not ApplicableCompleted

Comparing Hydrus Microstent(TM) to the iStent for Lowering IOP in Glaucoma Patients Undergoing Cataract Surgery

Role: lead

NCT04622605Not ApplicableCompleted

Hydrus Microstent and Lens Extraction for the Treatment of Primary Angle-Closure Glaucoma

Role: collaborator

NCT01539239Not ApplicableCompleted

Safety & Effectiveness Study of the Hydrus Microstent for Lowering IOP in Glaucoma Patients Undergoing Cataract Surgery (HORIZON)

Role: lead

NCT02023242Not ApplicableCompleted

Comparing Effectiveness of the Hydrus Microstent (TM) to Two iStents to Lower IOP in Phakic Eyes

Role: lead

NCT01818115Not ApplicableCompleted

Safety and Efficacy Trial to Evaluate the Hydrus(TM) Implant in Subjects Undergoing Cataract Surgery.

Role: lead

NCT03065036Phase 1Completed

Safety and Efficacy Study of the Hydrus Aqueous Implant in Subjects With POAG

Role: lead

All 7 trials loaded